Pancreaze
Payments companies reported to CMS as associated with Pancreaze. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pancreaze, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pancreaze
These are the largest totals companies reported as associated with Pancreaze. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Rubin | Merrick, NY | Gastroenterology (Internal Medicine) | $17,777.98 |
| Cynthia Rudert | Atlanta, GA | Gastroenterology (Internal Medicine) | $13,750.00 |
| Yevgeniy Mikityanskiy | Brooklyn, NY | Gastroenterology (Internal Medicine) | $5,145.80 |
| Oscar Chien | San Gabriel, CA | Geriatric Medicine (Internal Medicine) | $2,911.48 |
| Ronnie Cyzner | Charlotte, NC | Gastroenterology (Internal Medicine) | $605.45 |
| Maha Zikra | Orlando, FL | Endocrinology, Diabetes & Metabolism | $593.16 |
| Geovanna Deese | Charlotte, NC | Nurse Practitioner | $589.53 |
| Chun Tung Wong | New York, NY | Gastroenterology (Internal Medicine) | $574.41 |
| Po Chu | Brooklyn, NY | $572.35 | |
| Thadeus Dapash | Charlotte, NC | Gastroenterology (Internal Medicine) | $519.42 |
Prescribed Pancreaze?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.